Aerie pharmaceuticals, inc. reports earnings results for the third quarter ended september 30, 2019

Aerie pharmaceuticals, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced total revenue was usd 18.544 million compared to usd 7.302 million a year ago. operating loss was usd 43.327 million compared to usd 61.338 million a year ago. net loss was usd 49.402 million compared to usd 85.388 million a year ago. basic loss per share was usd 1.09 compared to usd 1.96 a year ago. for the nine months, total revenue was usd 45.231 million compared to usd 9.725 million a year ago. operating loss was usd 137.554 million compared to usd 157.817 million a year ago. net loss was usd 144.517 million compared to usd 181.111 million a year ago. basic loss per share was usd 3.19 compared to usd 4.47 a year ago.
AERI Ratings Summary
AERI Quant Ranking